Muscle News and Research RSS Feed - Muscle News and Research

Renaissance in drug development for rare diseases

Renaissance in drug development for rare diseases

Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ramping up research efforts and marketing new medicines that promise fuller lives for children and other patients with these heartbreaking conditions. [More]
Bowel cancer survival in the UK: an interview with Camille Maringe, London School of Hygiene and Tropical Medicine

Bowel cancer survival in the UK: an interview with Camille Maringe, London School of Hygiene and Tropical Medicine

Colorectal cancer is the third most common cancer in men and second in women, with over 1.2 million cases diagnosed worldwide in 2008. [More]
Noninvasive imaging tests may play bigger role in diabetes management

Noninvasive imaging tests may play bigger role in diabetes management

New approaches to applying noninvasive imaging tests such as computed tomography, magnetic resonance, and positron emission tomography may play a bigger role in evaluating and managing patients with diabetes. [More]

COSIRA trial: Enrollment complete for assessing Neovasc Reducer in refractory angina patients

Neovasc Inc., today announced the completion of patient enrollment in its COSIRA trial designed to further assess the efficacy and safety of the Neovasc Reducer, a novel percutaneous device for the treatment of refractory angina. [More]

Researchers discover that microRNAs link two defining characteristics of fit muscles

Researchers discovered that small pieces of genetic material called microRNAs link the two defining characteristics of fit muscles: the ability to burn sugar and fat and the ability to switch between slow- and fast-twitch muscle fibers. [More]
UA researchers discover genetic mutations that cause severe epilepsies in children

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers at the University of Arizona have successfully determined the genetic mutations causing severe epilepsies in seven out of 10 children for whom the cause of the disorder could not be determined clinically or by conventional genetic testing. [More]
Researchers identify genetic mutations that appear to underlie rare syndrome

Researchers identify genetic mutations that appear to underlie rare syndrome

Researchers from Massachusetts General Hospital and Duke University have identified genetic mutations that appear to underlie a rare but devastating syndrome combining reproductive failure with cerebellar ataxia - a lack of muscle coordination - and dementia. [More]
Study: Patients are more likely to have recurrence of cancer after bladder removal

Study: Patients are more likely to have recurrence of cancer after bladder removal

Patients with advanced bladder cancers that are surgically removed might need additional therapy to prevent recurrence in certain situations, a new UT Southwestern Medical Center study suggests. [More]
Restless legs syndrome and insomnia: a possible explanation

Restless legs syndrome and insomnia: a possible explanation

Johns Hopkins researchers believe they may have discovered an explanation for the sleepless nights associated with restless legs syndrome (RLS), a symptom that persists even when the disruptive, overwhelming nocturnal urge to move the legs is treated successfully with medication. [More]
Biomedical engineers grow 3D human heart muscle that acts just like natural tissue

Biomedical engineers grow 3D human heart muscle that acts just like natural tissue

Duke University biomedical engineers have grown three-dimensional human heart muscle that acts just like natural tissue. This advancement could be important in treating heart attack patients or in serving as a platform for testing new heart disease medicines. [More]
Rigel reports net loss of $25.6 million in first quarter 2013

Rigel reports net loss of $25.6 million in first quarter 2013

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2013. For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012. Weighted average shares outstanding for the first quarters of 2013 and 2012 were 87.1 million and 71.4 million, respectively. [More]

Study offers new hope to patients suffering from laminopathies

Laminopathies are hereditary diseases that affect mainly the muscle tissue. These diseases include for example Emery-Dreifuss Muscular dystrophy, dilated cardiomyopathy, limb-girdle muscular dystrophy and Hutchison-Gilford progeria syndrome. [More]
New report highlights factors that contribute to asthma

New report highlights factors that contribute to asthma

There is still no cure for asthma, so for 22 million people in the U.S., this chronic disease continues to be a daily burden no matter where they live. But it's not just air pollution they should be worried about. Factors such as pollen, secondhand smoke – even high rates of poverty, a large uninsured population or a high number of ER visits – can be critical signs that certain cities and states are worse for families with asthma. It is especially true for people with severe asthma. [More]

People who gain weight are more conscious of their decision-making, but still give in to temptations

People who gain weight are more likely to give in to temptations but also are more thoughtful about their actions, according to a new study published in Psychological Science, a journal of the Association for Psychological Science. [More]
800 IU of vitamin D3 per day is recommended for preterm infants, says study

800 IU of vitamin D3 per day is recommended for preterm infants, says study

Preterm infants may need to be given 800 international units (IU) of vitamin D a day to ensure they develop strong bones, according to a study to be presented Sunday, May 5, at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC. [More]

"Minimalist" shoes allow runner to imitate barefoot running, protect sole and toe

For tens of thousands of years, humans ran on bare feet. Then we developed an assortment of specialized shoes, including - particularly since the 1960s - a seemingly limitless variety of running shoes. [More]
Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

Cancer chemotherapy can cause peripheral neuropathy-nerve damage often resulting in pain and muscle weakness in the arms and legs. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that chemo also induces an insidious type of nerve damage inside bone marrow that can cause delays in recovery after bone marrow transplantation. [More]

New physical exercise programme improves muscle strength and balance in women with osteoporosis

Montserrat Otero, a UPV/EHU lecturer, has concluded that physical exercise done with basic materials improves muscle strength and balance in women with osteoporosis [More]

Discovery raises hope for severe forms of human epilepsy

Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy. [More]
Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LIPTRUZET (ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough. [More]